Already-listed Enliven Therapeutics, which develops small-molecule kinase inhibitors for cancer, revealed plans to raise $90 million through a private investment in public equity (PIPE ...
Oct. 9, 2024 — Researchers have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback